Use of a Mobile-based App for SCD Patients (SMART)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01833702|
Recruitment Status : Recruiting
First Posted : April 17, 2013
Last Update Posted : July 28, 2017
The study will seek to enroll 100 sickle cell or thalassemia patients who are age 12 or older who have access to a smartphone or tablet with Internet access daily.
The study will evaluate patient-reported comfort level with using a mobile device to record their pain levels, as well as adherence to recording these levels daily.
The study will track patients' assessment of their pain, actions taken, and outcomes related to pain management and provider involvement.
This study will attempt to collect information about differences in the use of two traditional pain assessment modes (verbal scale and paper) versus the use of a pain assessment tool on a mobile device in the form of a smartphone, tablet, or iPad with an Android or iOS operating system.
|Condition or disease|
|Sickle Cell Disease Chronic Pain|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Use of a Mobile-based Pain Assessment Application for SCD Patients|
|Study Start Date :||January 2015|
|Estimated Primary Completion Date :||December 2018|
|Estimated Study Completion Date :||December 2018|
Canned responses are provided at the end of daily entries
No automated feedback
Canned responses are not provided at the end of daily entries
- Usability [ Time Frame: 42 days ]Patients are able to use a mobile device to record daily symptoms, including pain, and interventions, including medication administration.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01833702
|Contact: Christle cameron, LPNemail@example.com|
|Contact: Jude Jonassaint, RNfirstname.lastname@example.org|
|United States, North Carolina|
|Duke University Medical Center||Recruiting|
|Durham, North Carolina, United States, 27710|
|Contact: Jude Jonassaint, RN 919-668-6035 email@example.com|
|Contact: Laura De Castro, MD 9196846464 firstname.lastname@example.org|
|Principal Investigator: Jude Jonassaint, RN|
|Sub-Investigator: Laura De Castro, MD|
|Sub-Investigator: Nirmish Shah, MD|
|Principal Investigator:||Jude Jonassaint, RN||Duke University|
|Principal Investigator:||Laura De Castro, MD||Duke University|
|Principal Investigator:||Nirmish Shah, MD||Duke University|